Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

MYCOBACTERIUM LEPRAE - ANVISA Registration 80502070132

Access comprehensive regulatory information for MYCOBACTERIUM LEPRAE in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80502070132 and manufactured by MOBIUS LIFE SCIENCE INDÚSTRIA E COMERCIO DE PRODUTOS PARA LABORATÓRIOS LTDA. The registration is held by MOBIUS LIFE SCIENCE INDUSTRIA E COMERCIO DE PRODUTOS PARA LABORATORIOS LTDA with validity until Mar 31, 2035.

This page provides complete technical specifications for this device, regulatory compliance details, 3 companies making the same product including INSTITUTO DE BIOLOGIA MOLECULAR DO PARANÁ, QUIBASA QUÍMICA BÁSICA LTDA, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
3 Competitors
4 Recent Registrations
80502070132
Registration Details
ANVISA Registration Number: 80502070132
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

XGEN MASTER LEPRAE
Risk Class III

Registration Details

80502070132

25351446671202440

04645160000149

Dates and Status

Mar 31, 2025

31/03/2035

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "MYCOBACTERIUM LEPRAE"